Corpus ID: 49331933

Antibody drug conjugates (ADC) : Current status and mapping of ADC:s in clinical programs

@inproceedings{Congreve2018AntibodyDC,
  title={Antibody drug conjugates (ADC) : Current status and mapping of ADC:s in clinical programs},
  author={Samantha Congreve and Reham Faris Elias and Gabriel Tidestav and Venus Zafranian},
  year={2018}
}
  • Samantha Congreve, Reham Faris Elias, +1 author Venus Zafranian
  • Published 2018
  • Medicine
  • A literature study was performed on a new type of cancer medicine: antibody drug conjugates, or ADCs. These consist of a monoclonal antibody, chemically linked to a cytotoxic agent. What makes them ... 
    1 Citations

    Figures, Tables, and Topics from this paper

    Explore Further: Topics Discussed in This Paper

    References

    SHOWING 1-10 OF 28 REFERENCES
    Antibody-drug conjugates—an emerging class of cancer treatment
    • 253
    • PDF
    Advances in antibody-drug conjugates: A new era of targeted cancer therapy.
    • 74
    Pharmacokinetics of Monoclonal Antibodies
    • 187
    The antibody–drug conjugate target landscape across a broad range of tumour types
    • 23
    ADME of Antibody–Maytansinoid Conjugates
    • 92